CapitolRadar tracks every publicly disclosed CVS trade by US congress members and corporate insiders: 75 disclosed trades (43 buys, 32 sells) by 4 tracked traders, from 2020-11-17 to 2026-09-04. Updated daily from official filings.
Want a ping when Congress buys CVS? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
CVS Health Corp. (CVS) — Healthcare · Medical - Healthcare Plans, market cap about $112.2B.
CapitolRadar analysis
42 trades, with buys concentrated in one disclosed trader
CVS Health Corp. (CVS), in the Healthcare / Medical - Healthcare Plans industry, recorded 42 tracked trades from January 21, 2022 through June 2, 2026. The activity comprised 26 buys and 16 sells by two distinct traders. Ro Khanna accounted for all 26 reported buys, with the latest dated June 2, 2026. The data does not identify the seller or sellers, so the 16 sales cannot be attributed more specifically.
Although the overall count leans toward purchases, the sample is narrow: only two distinct traders appear in the tracked record, and all disclosed buying came from one person. That concentration limits how broadly the 26-to-16 buy/sell split can be interpreted.
2023 Q2 led the listed quarterly activity
Eight trades appeared in 2023 Q2, including six buys—the largest quarterly count among the periods provided. The following quarter had three trades, two of them buys, while 2023 Q4 contained two trades and both were purchases. In 2024, Q1 had one sale, Q2 had one buy, and Q3 had three trades with one buy.
The 2026 entries show one sale in Q1 followed by three buys in Q2. These listed quarters do not account for all 42 tracked trades, so they should be read as a partial quarterly view rather than a complete chronology.
Six co-purchased tickers, each linked to one buyer
Among CVS buyers, one also bought each of ACGL, AMZN, BR, COO, EME and GOOGL. Because the CVS buyer sample is effectively one disclosed buyer, these overlaps describe that individual’s reported activity rather than a recurring pattern across multiple purchasers.
Congressional disclosures can be filed up to 45 days after a transaction, so reported activity may lag the underlying trade date. Disclosed transaction amounts are generally presented as ranges, making any amount-based totals estimates; no transaction amounts were provided here. The two-trader sample is small and does not establish broader sentiment toward CVS.
Analysis written from the tracked record on 2026-08-31; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 1 | 0 | 1 |
| 2026 Q2 | 3 | 3 | 0 |
| 2026 Q1 | 2 | 0 | 2 |
| 2025 Q2 | 1 | 0 | 1 |
| 2025 Q1 | 1 | 1 | 0 |
| 2024 Q3 | 3 | 1 | 2 |
| 2024 Q2 | 2 | 2 | 0 |
| 2024 Q1 | 1 | 0 | 1 |
Who is buying CVS?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 26 | 2026-06-02 | — |
| Michael McCaul | 13 | 2025-01-13 | — |
| Diana Harshbarger | 4 | 2022-08-12 | — |
Disclosed trades in CVS
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-04 | Ro Khanna | sell | $15,001 - $50,000 | — |
| 2026-06-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-05-01 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-04-13 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-01-29 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-01-13 | Michael McCaul | sell | $15,001 - $50,000 | — |
| 2025-04-10 | Michael McCaul | sell | $100,001 - $250,000 | — |
| 2025-01-13 | Michael McCaul | buy | $100,001 - $250,000 | — |
| 2024-09-09 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-09-09 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2024-08-26 | Tommy Tuberville | sell | $1,001 - $15,000 | — |
| 2024-06-05 | Michael McCaul | buy | $1,001 - $15,000 | — |
| 2024-05-07 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-02-02 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2023-10-06 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-09-12 | Michael McCaul | buy | $1,001 - $15,000 | — |
| 2023-09-12 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2023-09-06 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2023-08-29 | Ro Khanna | sell | $1,001 - $15,000 | — |
These buyers also bought
Other stocks the tracked buyers of CVS disclosed buying in the last six months: TSM (2) · AJG (2) · DHR (2) · MA (2) · META (2) · TER (2).
About CVS Health Corp.
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The …
Frequently asked questions
Which politicians bought CVS most?
Ro Khanna leads with 26 disclosed buys, followed by Michael McCaul.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.